Dean J Naisbitt Selected Research

Dean J Naisbitt Research Topics

Disease

40	Hypersensitivity (Allergy) 01/2023 - 09/2002
12	Drug Hypersensitivity (Drug Allergy) 01/2023 - 01/2004
9	Chemical and Drug Induced Liver Injury 07/2023 - 01/2015
6	Cystic Fibrosis (Mucoviscidosis) 01/2022 - 06/2010
6	Allergic Contact Dermatitis 10/2015 - 02/2007
5	Stevens-Johnson Syndrome (Lyell's Syndrome) 01/2023 - 03/2011
5	Drug-Related Side Effects and Adverse Reactions 01/2022 - 01/2007
4	Exanthema (Rash) 01/2023 - 06/2003
4	Iatrogenic Disease 01/2021 - 02/2013
3	Autosomal Dominant Polycystic Kidney (ADPKD) 01/2023 - 11/2020
2	Gram-Positive Bacterial Infections 01/2024 - 01/2022
2	Drug Hypersensitivity Syndrome 01/2024 - 01/2021
2	Neoplasms (Cancer) 10/2023 - 04/2013
2	Infections 01/2022 - 01/2021
2	Cicatrix (Scar) 01/2022 - 01/2021
2	Contact Dermatitis (Eczema, Contact) 03/2010 - 03/2009
1	Skin Diseases (Skin Disease) 10/2023
1	Cholestasis 01/2023
1	COVID-19 01/2021
1	Alzheimer Disease (Alzheimer's Disease) 01/2021
1	Eosinophilia 01/2021
1	Agranulocytosis (Granulocytopenia) 11/2020
1	Immediate Hypersensitivity 10/2020
1	Hepatitis C 01/2019
1	Virus Diseases (Viral Diseases) 01/2019
1	Meningism (Meningismus) 01/2017
1	Tuberculosis (Tuberculoses) 01/2017
1	Genetic Predisposition to Disease (Genetic Predisposition) 01/2016

Drug/Important Bio-Agent (IBA)

12	Proteins (Proteins, Gene)FDA Link 01/2023 - 01/2005
12	AntigensIBA 10/2020 - 09/2002
11	Sulfamethoxazole FDA LinkGeneric 01/2021 - 09/2002
10	Anti-Bacterial Agents (Antibiotics)IBA 01/2024 - 06/2010
8	abacavir (Ziagen)FDA Link 01/2020 - 05/2003
7	Carbamazepine (Tegretol)FDA LinkGeneric 01/2023 - 07/2006
7	LactamsIBA 01/2023 - 06/2012
7	HLA Antigens (Human Leukocyte Antigens)IBA 01/2022 - 05/2013
7	4-phenylenediamine (p-phenylenediamine)FDA Link 10/2015 - 02/2007
6	HLA-B Antigens (HLA-B)IBA 01/2023 - 05/2007
6	HLA-B57 antigenIBA 01/2020 - 11/2012
6	Tuberculin (PPD)IBA 10/2015 - 02/2007
5	HaptensIBA 01/2023 - 09/2011
5	Piperacillin FDA LinkGeneric 01/2018 - 07/2011
4	Anticonvulsants (Antiepileptic Drugs)IBA 01/2023 - 01/2004
4	Floxacillin (Flucloxacillin)IBA 01/2023 - 02/2013
3	Vancomycin FDA LinkGeneric 01/2024 - 01/2021
3	GlycopeptidesIBA 01/2024 - 01/2021
3	Tolvaptan FDA Link 01/2023 - 11/2020
3	Dapsone FDA Link 01/2023 - 01/2019
3	Peptides (Polypeptides)IBA 01/2023 - 01/2020
3	Amoxicillin (Wymox)FDA LinkGeneric 11/2020 - 10/2016
3	Clavulanic Acid (Potassium Clavulanate)FDA LinkGeneric 11/2020 - 10/2016
3	SulfonamidesIBA 08/2014 - 02/2010
2	HLA-A Antigens (HLA-A)IBA 01/2024 - 01/2021
2	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2022 - 01/2020
2	lumacaftorIBA 01/2022 - 01/2021
2	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2016
2	MicroRNAs (MicroRNA)IBA 01/2021 - 01/2018
2	Penicillins (Penicillin)FDA Link 12/2017 - 09/2011
2	Isoniazid (Ftivazide)FDA LinkGeneric 01/2017 - 01/2015
2	Bandrowski's baseIBA 10/2015 - 04/2008
2	Hair DyesIBA 10/2015 - 02/2007
1	ErbB Receptors (EGF Receptor)IBA 10/2023
1	HLA-C Antigens (HLA-C)IBA 10/2023
1	Ibuprofen (Motrin)FDA LinkGeneric 07/2023
1	Naproxen (Naprosyn)FDA LinkGeneric 07/2023
1	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 07/2023
1	Histocompatibility Antigens Class IIIBA 01/2023
1	TeicoplaninIBA 01/2022
1	ivacaftorIBA 01/2022
1	Genetic Markers (Genetic Marker)IBA 01/2022
1	LigandsIBA 01/2021
1	AcidsIBA 01/2021
1	C-Reactive ProteinIBA 01/2021
1	Sulfamethoxazole Drug Combination Trimethoprim (Co-Trimoxazole)FDA LinkGeneric 01/2021
1	atabecestatIBA 01/2021
1	von Willebrand FactorIBA 01/2021
1	Antiviral Agents (Antivirals)IBA 01/2021
1	Antipsychotic Agents (Antipsychotics)IBA 11/2020
1	Clozapine (Clozaril)FDA LinkGeneric 11/2020
1	Protease Inhibitors (Protease Inhibitor)IBA 01/2019
1	InterferonsIBA 01/2019
1	Ribavirin (Virazole)FDA LinkGeneric 01/2019
1	telaprevirIBA 01/2019
1	Immunoglobulin G (IgG)IBA 12/2017
1	AntibodiesIBA 12/2017
1	Pyrazinamide FDA LinkGeneric 01/2017
1	Rifampin (Rifampicin)FDA LinkGeneric 01/2017
1	Trimethoprim (Proloprim)FDA LinkGeneric 01/2017
1	Ethambutol (Myambutol)FDA LinkGeneric 01/2017
1	Lapatinib (GW572016)FDA Link 12/2016
1	lumiracoxib (prexige)IBA 12/2016
1	Oxypurinol (Oxipurinol)IBA 12/2016
1	ximelagatran (Exanta)IBA 12/2016
1	NucleosidesIBA 04/2014
1	Reverse Transcriptase InhibitorsIBA 04/2014
1	HLA-DRB1*04 antigenIBA 02/2014
1	HLA-A31 antigenIBA 02/2014

Therapy/Procedure

3	Therapeutics 01/2021 - 04/2007
2	Drug Therapy (Chemotherapy) 07/2006 - 01/2004
1	Transplantation 08/2015